DT

Draig Therapeutics at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Draig Therapeutics brings 2 presentations to SfN 2026 in Washington. Its SfN 2026 presentations centre on preclinical drug candidates for cognition and anxiety. One thread explores a selective GABA A receptor modulator with anxiety-reducing effects and no sedation.

OrganizationSfN 2026 Attendance
DT
Draig Therapeutics
Cardiff, UK
Drug developers
Biotechnology company developing therapies for neurological and psychiatric disorders in Cardiff, United Kingdom.

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Draig Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction